Journal
JOURNAL OF CLINICAL HYPERTENSION
Volume 22, Issue 5, Pages 792-801Publisher
WILEY
DOI: 10.1111/jch.13867
Keywords
-
Categories
Funding
- Bloomberg Philanthropies
- Bill and Melinda Gates Foundation
- Gates Philanthropy Partners
- Chan Zuckerberg Foundation
Ask authors/readers for more resources
High blood pressure (BP) is the single leading preventable cardiovascular disease (CVD) risk factor across the world. In order to decrease the global burden of CVD, broad hypertension screening programs that facilitate early hypertension diagnosis and treatment are essential. Accurate BP devices are a key element of hypertension control programs. With the overwhelming number of devices available now on the market, most of which have not been tested for accuracy, it can be challenging to select the optimal BP measurement device for clinical settings. This review details essential factors to consider when selecting a good-quality BP device, particularly for use in low-resource settings. Barriers to the procurement and use of good-quality devices are reviewed and practical solutions proposed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available